In 2023, Ajanta Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Ajanta Pharma generated a total of 2,414 metric tonnes of waste.
Of this amount, 86.34% of Ajanta Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 20.53% was disposed of through landfilling, incineration, or combustion.
In 2023, Ajanta Pharma reported a total waste generation of 2,414 metric tonnes, of which 86.34% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Ajanta Pharma has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Since 2023, Ajanta Pharma's total waste generation has decreased by 2.62%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.
Over the same period, Ajanta Pharma's waste recovery rate decreased by 1.16%.
In 2023, Ajanta Pharma generated a total of 2,414 metric tonnes of waste.
Of this amount, 21.61% of Ajanta Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 78.39% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2023, Ajanta Pharma's total waste generation has decreased by 2.62%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.
Overall, Ajanta Pharma's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
In 2023, Ajanta Pharma reported that 522 metric tonnes of its total waste output were classified as hazardous. This represents 21.61% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Approximately 36.78% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.